Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: Current state of the art

被引:128
作者
Oberbauer E. [1 ,2 ]
Steffenhagen C. [1 ,2 ]
Wurzer C. [1 ,2 ]
Gabriel C. [1 ,2 ,3 ]
Redl H. [1 ,2 ]
Wolbank S. [1 ,2 ]
机构
[1] Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Center, Linz/Vienna
[2] Austrian Cluster for Tissue Regeneration, Vienna
[3] Red Cross Blood Transfusion Service of Upper Austria, Linz
关键词
Adipose-derived stromal/stem cells; Enzymatic; Human adipose tissue; Isolation systems; Non-enzymatic; Stromal vascular fraction;
D O I
10.1186/s13619-015-0020-0
中图分类号
学科分类号
摘要
In the past decade, adipose tissue became a highly interesting source of adult stem cells for plastic surgery and regenerative medicine. The isolated stromal vascular fraction (SVF) is a heterogeneous cell population including the adipose-derived stromal/stem cells (ASC), which showed regenerative potential in several clinical studies and trials. SVF should be provided in a safe and reproducible manner in accordance with current good manufacturing practices (cGMP). To ensure highest possible safety for patients, a precisely defined procedure with a high-quality control is required. Hence, an increasing number of adipose tissue-derived cell isolation systems have been developed. These systems aim for a closed, sterile, and safe isolation process limiting donor variations, risk for contaminations, and unpredictability of the cell material. To isolate SVF from adipose tissue, enzymes such as collagenase are used. Alternatively, in order to avoid enzymes, isolation systems using physical forces are available. Here, we provide an overview of known existing enzymatic and non-enzymatic adipose tissue-derived cell isolation systems, which are patented, published, or already on the market. © 2015 Oberbauer et al.
引用
收藏
相关论文
共 165 条
[71]  
Thesleff T., Lehtimaki K., Niskakangas T., Mannerstrom B., Miettinen S., Suuronen R., Et al., Cranioplasty with adipose-derived stem cells and biomaterial: a novel method for cranial reconstruction, Neurosurgery, 68, 6, pp. 1535-1540, (2011)
[72]  
Tanikawa D.Y., Aguena M., Bueno D.F., Passos-Bueno M.R., Alonso N., Fat grafts supplemented with adipose-derived stromal cells in the rehabilitation of patients with craniofacial microsomia, Plast Reconstr Surg, 132, 1, pp. 141-152, (2013)
[73]  
Zuk P., Adipose-derived stem cells in tissue regeneration: a review, ISRN Stem Cells, 2013, (2013)
[74]  
Castro-Malaspina H., Gay R.E., Resnick G., Kapoor N., Meyers P., Chiarieri D., Et al., Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny, Blood, 56, 2, pp. 289-301, (1980)
[75]  
EudraLex., Clinical trial guidelines, 10, (2010)
[76]  
EudraLex., Good manufacturing practice (GMP), 4, (2015)
[77]  
Aarya Hari S.G., Production of good manufacturing practice grade equine adiposederived mesenchymal stem cells for therapeutic use, J Stem Cell Res Ther, 3, 5, pp. 2157-7633, (2013)
[78]  
Sensebe L., Gadelorge M., Fleury-Cappellesso S., Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review, Stem Cell Res Ther, 4, 3, (2013)
[79]  
Carvalho P.P., Gimble J.M., Dias I.R., Gomes M.E., Reis R.L., Xenofree enzymatic products for the isolation of human adipose-derived stromal/stem cells, Tissue Eng Part C Meth, 19, 6, pp. 473-478, (2013)
[80]  
Patrikoski M., Juntunen M., Boucher S., Campbell A., Vemuri M.C., Mannerstrom B., Et al., Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells, Stem Cell Res Ther, 4, 2, (2013)